Cart
sales@molnova.com
Pherocon (4-(4-Acetoxyphenyl)-2-butanone)
CAS No. 3572-06-3
Pherocon (4-(4-Acetoxyphenyl)-2-butanone)( Cue-lure | Q-lure | Cuelure )
Catalog No. M21348 CAS No. 3572-06-3
Pherocon (4-(4-Acetoxyphenyl)-2-butanone) is a standard melon fly attractant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 45 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePherocon (4-(4-Acetoxyphenyl)-2-butanone)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPherocon (4-(4-Acetoxyphenyl)-2-butanone) is a standard melon fly attractant.
-
DescriptionPherocon (4-(4-Acetoxyphenyl)-2-butanone) is a standard melon fly attractant.
-
In Vitro——
-
In Vivo——
-
SynonymsCue-lure | Q-lure | Cuelure
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3572-06-3
-
Formula Weight206.24
-
Molecular FormulaC12H14O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (484.87 mM)
-
SMILESCC(CCc(cc1)ccc1OC(C)=O)=O
-
Chemical Name4-(3-oxobutyl)phenyl acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CRF, bovine TFA
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. CRF shows pEC50s of 11.16, 8.53 and 8.70 for human CRF1, human CRF2 and rat CRF2α.
-
Eculizumab
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.
-
Apamin TFA
Apamin TFA (Apamine TFA) is a toxin found in bee venom. It is a potent blocker of small conductance Ca2+-activated K+ (SK, KCa2) channels that is more effective at SK2 than SK1 and SK3.
